Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 4/20 | 0.56 |
| ▸ | EHMT2 | Q96KQ7 | 4/20 | 0.56 |
| ▸ | EHMT1 | Q9H9B1 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | HTR6 | P50406 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 4/20 | 0.33 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA9 | Q16790 | 4/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | CA7 | P43166 | 3/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA3 | P07451 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL150725 | 0.96 | BBOX1 (0.60) | BBOX1EHMT2EHMT1ALDH1A1MAOA | |
| Bromide SCHEMBL9069068 | 0.92 | BBOX1 (0.56) | BBOX1EHMT2EHMT1ALDH1A1MAOA | |
| Hydrochloric Acid SCHEMBL1157944 | 0.92 | BBOX1 (0.56) | BBOX1EHMT2EHMT1ALDH1A1MAOA | |
| Bromide SCHEMBL31300172 | 0.92 | BBOX1 (0.56) | BBOX1EHMT2EHMT1ALDH1A1MAOA | |
| Hydrochloric Acid SCHEMBL3629169 | 0.92 | BBOX1 (0.56) | BBOX1EHMT2EHMT1ALDH1A1MAOA | |
| Bromide SCHEMBL9069066 | 0.92 | BBOX1 (0.56) | BBOX1EHMT2EHMT1ALDH1A1MAOA | |
| Hydrochloric Acid SCHEMBL30039649 | 0.92 | BBOX1 (0.56) | BBOX1EHMT2EHMT1ALDH1A1MAOA | |
| Phosphine SCHEMBL14917741 | 0.92 | BBOX1 (0.56) | BBOX1EHMT2EHMT1ALDH1A1MAOA | |
| Hydrochloric Acid SCHEMBL10533844 | 0.89 | BBOX1 (0.53) | BBOX1EHMT2EHMT1ALDH1A1MAOA | |
| Hydrochloric Acid SCHEMBL10525049 | 0.89 | BBOX1 (0.53) | BBOX1EHMT2EHMT1ALDH1A1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220378738-A1 | (+)-TRANS TETRAHYDROCANNABINOL ((+)-TRANS-THC) FOR USE AS A MEDICAMENT | JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (GB) | 2022-12-01 | — | — | US | disclosed |
| CN-114786664-A | (+) -Trans tetrahydrocannabinol ((+) -Trans-THC) as a medicament | 吉伟研究有限公司 | 2022-07-22 | — | — | CN | disclosed |
| US-11242296-B2 | Decomposition of organic peroxides and hydrogen peroxide by the iron thiolates and related complexes | NUTECH VENTURES (US) | 2022-02-08 | — | — | US | disclosed |
| WO-2021079137-A1 | (+)-TRANS TETRAHYDROCANNABINOL ((+)-TRANS-THC) FOR USE AS A MEDICAMENT | GW Research Limited (GB) | 2021-04-29 | — | — | WO | disclosed |
| CN-105152992-B | Cyclopiane tetracyclic diterpene analogue and synthesis method and application thereof | 兰州大学 | 2021-01-26 | — | — | CN | disclosed |
| US-20200181038-A1 | DECOMPOSITION OF ORGANIC PEROXIDES AND HYDROGEN PEROXIDE BY THE IRON THIOLATES AND RELATED COMPLEXES | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2020-06-11 | — | — | US | disclosed |
| US-6855708-B2 | N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors | MERCK & CO., INC. (US) | 2005-02-15 | — | — | US | disclosed |
| US-20040171072-A1 | Solid support based on selenium useful in solid phase synthesis | H. LUNDBECK A/S (DK) | 2004-09-02 | — | — | US | disclosed |
| US-20030008861-A1 | N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors | MERCK & CO., INC. | 2003-01-09 | — | — | US | disclosed |
| EP-1086153-A1 | A SOLID SUPPORT BASED ON SELENIUM USEFUL IN SOLID PHASE SYNTHESIS | H. LUNDBECK A/S (DK) | 2001-03-28 | — | — | EP | disclosed |
| CN-1106403-A | 3-hydroxy-4-hydroxymethyl-2-methylenecyclopentyl purines and pyrimidines | BRISTOL MYERS SQUIBB CO (US) | 1995-08-09 | — | — | CN | disclosed |
| EP-0630897-A2 | 3-Hydroxy-4-hydroxymethyl-2-methylene-cyclopentyl purines and pyrimidines | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-12-28 | — | — | EP | disclosed |
| EP-0343734-B1 | CATALYST COMPOSITIONS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1993-08-11 | — | — | EP | disclosed |
| EP-0211954-B1 | USE OF (+/-)-CIS-GAMMA-IRONE IN PERFUMERY AND NOVEL PROCESS FOR PREPARING SAME | T. HASEGAWA COMPANY, LTD. (JP) | 1991-07-17 | — | — | EP | disclosed |
| WO-1991001318-A1 | SYNTHESIS OF CYCLOPENTENE DERIVATIVES | GLAXO GROUP LIMITED (GB) | 1991-02-07 | — | — | WO | disclosed |
| US-4948870-A | Polymerization process | SHELL OIL COMPANY (US) | 1990-08-14 | — | — | US | disclosed |
| US-4900782-A | Stabilized polyelectrolyte precursors of poly(aromatic and heteroaromatic vinylenes) | ALLIED-SIGNAL INC. (US) | 1990-02-13 | — | — | US | disclosed |
| EP-0343734-A1 | Catalyst compositions | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-11-29 | — | — | EP | disclosed |
| EP-0211954-A1 | USE OF (+/-)-CIS-GAMMA-IRONE IN PERFUMERY AND NOVEL PROCESS FOR PREPARING SAME | T. HASEGAWA COMPANY, LTD. (JP) | 1987-03-04 | — | — | EP | disclosed |
| US-4281148-A | FROM EPOXIDE AND TRIORGANOSILYLTRIFLUOROMETHANESULFONATE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1981-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220378738-A1 | (+)-TRANS TETRAHYDROCANNABINOL ((+)-TRANS-THC) FOR USE AS A MEDICAMENT | CNR2, CNR1, FAAH | BBOX1 1105/4885EHMT2 1513/4885EHMT1 1913/4885 |
| US-20200181038-A1 | DECOMPOSITION OF ORGANIC PEROXIDES AND HYDROGEN PEROXIDE BY THE IRON THIOLATES AND RELATED COMPLEXES | GPX4, LPO, CAT | BBOX1 526/4885EHMT2 1720/4885EHMT1 2623/4885 |
| US-20030008861-A1 | N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors | VCAM1, CD4, ITGA4 | BBOX1 2924/4885EHMT2 2553/4885EHMT1 2083/4885 |
| US-11242296-B2 | Decomposition of organic peroxides and hydrogen peroxide by the iron thiolates and related complexes | GPX4, LPO, CAT | BBOX1 526/4885EHMT2 1720/4885EHMT1 2623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.